NCT02868255View on ClinicalTrials.gov

Myeloid Derived Suppressor Cells Control by Signal Regulatory Protein-alpha: Investigation in Hepatocellular Carcinoma

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

January 3, 2016

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Hepatocellular Carcinoma
Interventions
PROCEDURE

Collection of human samples

Several types of samples will be used to test the effect of the drug candidate

All Listed Sponsors
collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

Nantes University Hospital

OTHER

NCT02868255 - Myeloid Derived Suppressor Cells Control by Signal Regulatory Protein-alpha: Investigation in Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter